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INTRODUCTION:  Pancreatic  schwannoma  (PS) is  an  extremly  rare  benign  tumor.  Less  than  50 cases  of
pancreatic  schwannoma  have  been  described  in  the  English  literature  over  the  past thirty  years.
PRESENTATION  OF CASE  REPORT:  A  63-year-old  female  underwent  left  modiﬁed  radical  mastectomy  2
years ago  due  to breast  cancer.  During  her routine  check-up,  a 65  ×  63  × 55  mm  measured  calciﬁed,  well-
demarcated,  cystic-mass  having  septations  and  calciﬁcations  that  localized  to  the  pancreatic  head  was
detected by  abdominal  computerized  tomography.  She  was  asymptomatic  and  her  tumor  markers  were
in normal  ranges.  A  standard  Whipple  procedure  was  performed,  and  the  histo-pathological  diagnosis  of
the  resected  specimen  was  reported  as  ancient  schwannoma  with  clear  surgical  margins.  Patient’s  post-
operative course  was  eventful.  She  had  a  biliary  leakage  after  surgery  which  was  managed  conservatively.
She  is  under  follow-up.
DISCUSSION: Pancreatic  schwannoma  also  known  as neurilemoma  or neuroma  is  a slowly  growing,
encapsulated,  mostly  benign  tumor  with  smooth  well-delineated  margins  that  originates  from  myelin
producing  schwann  cells  located  on  the  nerve  sheath  of  the  peripheral  epineurium  of either  the  sympa-
thetic  or  parasympathetic  autonomic  ﬁbers.  PS’s  are  extremly  rare.  The  head  of pancreas  being  involved
in the  vast  majority  of  cases  (40%),  followed  by its  body  (20%).  Management  of pancreatic  schwanno-
mas  remains  largely  controversial.  Both  enucleation  and  radical  surgical  resections  have revealed  great
therapeutic  efﬁciency.  with  a well  prognosis  without  recurrences.
CONCLUSION:  Although  rare,  PS’s  should  be  considered  in  the  differential  diagnosis  of  the  other  solid  or
cystic masses  of  the pancreas.
© 2016  The  Authors.  Published  by Elsevier  Ltd.  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
he  CCaccess  article  under  t
. Introduction
Schwannoma or neurilemmoma is usually a benign tumor
hich arises from schwann cells that present in the sheath of cra-
ial, spinal nerve roots and peripheral nerves [1,2]. Schwannom
s seen in extremities, head, neck, retroperitonum, mediastinum,
elvis and rectum [2,4]. PS is an extremely rare and equally hold
oth genders in adults [5,6]. Less than 50 cases of pancreatic
chwannoma have been described in the English literature over
he past thirty years. The behaviour of this tumor is not clear
hich can show sometimes malignant degeneration. Two thirds
f PS’s have degenerative changes such as cystic formation, cal-
iﬁcation, and hemorrhage mimicking pancreatic cystic tumors
5,6,8]. Patients with PS have usually abdominal pain, nausea and
omiting. Weight loss and jaundice may  sometimes accompany
5–7]. Diagnosis of preoperative PS is very difﬁcult and contrast
nhanced computed tomography (CT), ultrasonography (USG) or
∗ Corresponding author.
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ultrasonography-guided ﬁne-needle aspiration (USG-FNA) may
helpful [8–10]. Surgery is the only curative treatment modality
consisting of a variaty options changing from the simple enu-
cleation to pancreaticoduodenectomy [3,6,11,12]. The following
report presents a case with PS who  underwent Whipple procedure
for a preoperative assumed diagnosis of a pancreatic cystic tumor,
with review of literatures.
2. Case report
A 63-year-old female patient underwent modiﬁed radical mas-
tectomy and axillary dissection two  years ago due to left breast
cancer (BC). During her follow-up, a cystic mass of the pancreatic
head was  dedected on abdominal CT. Her tumor markers were in
normal range. A complex cystic mass measuring 5.5 × 4.5 mm in
diameter with rough calciﬁcations focusing on the internal struc-
ture having high density mural nodulation and irregularities in the
location of uncinat process was detected by abdominal USG. Con-
trast enhanced CT detected a cystic lesion 65 × 63 × 55 mm  in size
with smooth contoured wall including calciﬁcations and septa that
hold contrast and also contained millimetric nodules and soft tissue
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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Fig. 2. The spindle cells with composed of eosinophilic cytoplasm and indistinct
boundaries (Hematoxylin and Eosin) (H&E).
Fig. 3. Compact hypercellular and edematous hypocellular areas in pancreatic
schwannoma (H&E).ig. 1. CT image of pancreatic schwannoma in relation with duodenum, pancreas
nd vascular structures (red arrow).
omponents with no distant metastasis or intraabdominal lym-
hadenomegaly (Fig. 1). An explorative laparatomy was  planned
ollowing the anesthesia consultation, which determined her
hysical status as ASA-2 (American Society of Anesthesiologists).
ollowing a bilateral subcostal incision, a tumoral mass measuring
pproximately 5 cm in diameter with well-circumscribed, encap-
ulated hard wall in consistency, involving head of the pancreas
nd uncinate process was found. The tumor mass did not com-
ress the main biliary tract and there was no dilatation in the
ancreatic canal (approximately 2 mm).  A standart Whipple pro-
edure was performed. In the postoperative period, biliary leakage
ad been developed which resolved under conservative treatment.
istopathological examination of the resected specimen revealed a
ystic lesion that included an organized hematoma with indistinct
ome solid ﬁelds in the peripheral areas Microscopically, dif-
use signs of degeneration like hemorrhage, organized hematoma,
dema, stromal hyalinization, dystrophic calciﬁcation, and hyalin-
zation in vascular walls was detected. The tumor had a thick
bro-hyaline capsule which was well separated from the surround-
ng pancreatic tissue. In immunohistochemical staining, the tumor
as diffusely and severely stained with S-100 and vimentin, but it
as not stained with CD117 (C-kit), CD34, DOG-1, actin and desmin
Figs. 2–4). Her general condition is now well and she receives
egular follow-up care at the Oncology and General Surgery depart-
ents.
. Discussion
Pancreatic schwannoma also known as neurilemoma or neu-
oma is a slowly growing, encapsulated, mostly benign tumor with
mooth well-delineated margins that originates from myelin pro-
ucing schwann cells located on the nerve sheath of the peripheral
pineurium of either the sympathetic or parasympathetic auto-
omic ﬁbers [13,14]. In 1910, it was ﬁrstly named ‘neuroma’ by
erocay [1] and then Stout [2] changed its name ‘neurilemmo’
nd ﬁnally it was demonstrated that schwann cells proliferated in
umor in electron microscopy. Schwannomas are usually benign,
mooth-limited, encapsulated and slowly growing tumors [1–3].
hey are frequently seen at the 3th and 5th decades and equally
ffect both genders [2,3]. Moriya et al. [3] with their 47 schwan-
oma cases, reported the mean age as 55.7 years (20–87) with a
eing higher female ratio (female/male = 26/21) [3]. In patients with
on Recklinghausen disease, schwannomas are seen more often
ith an increased malignant transformation [5]. Our patient was
Fig. 4. The degenerative nuclear atypic areas (ancient modiﬁcation) (H&E).
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3 years old. PSs are frequently seen in the head and neck areas
25–48%) and they are less detected in the surface of the ﬂexor
xtremities, posterior mediastinum, pelvis, rectum, and retroperi-
oneum [4–6]. They are unilaterally located without abbreviations
nd the most common involved localization is intracranial area.
ajority of schwannomas are originated from VIII. cranial nerve
acoustic neuroma) and less frequently involved cranial nerves are
he 5th cranial nerve (trigeminal neuroma), II., IX., X. and XII nerves,
espectively. PS is extremely rare and made up less than 1% of all
chwannomas [3–5]. PS’s are derived from autonomic sympathetic
nd parasympathetic ﬁbers or branch of nervous vagus extending to
he pancreas [4–6]. According to the location of PS’s, they are mostly
ocated in the head (40%), followed by corpus (21%), neck (6%),
ail (15%), and uncinate process (13%), respectively. Two-thirds
f the tumors are cystic [6,12]. Because of their slowly growing
ehaviour, degeneration like hemorrhage, cyst formation, necro-
is and calciﬁcation may  occur and this condition is more often
een in schwannomas. This type of schwannomas is referrred as
degenerative or ancient schwannoma” which can often mimic
ancreatic cystic neoplasms, neuroendocrine tumors, cystade-
oma, cystadenocarcinoma, intraductal papillary mucinous tumor,
ymphangioma and pancreatic pseudocyst [7,15]. The present case
as features of ancient PS. The classic schwannomas histopatho-
ogically include two basic tumoral patterns; Antony A and Antony
 [3,15]. The Antony A pattern has a spindle-long cell which shows
 tight fence and higher cells with nuclear double-sequence ﬁeld
palisading) (Figs. 2–4). The Antony B pattern has a loose distri-
ution of the cells with varying degrees of lipoidization (Fig. 2).
n Antony A pattern, the tumor cell nuclei are in certain order
equence line as long axes to be parallel to each other (the nuclear
alisading) and these areas are called ‘Verocay bodies’ (Fig. 2).
he roof of vessel is typically thick-walled containing hyaline. The
ncient schwannomas have intranuclear cytoplasmic inclusions
nd bizarre cells containing nuclear pleomorphism (Fig. 4). The cel-
ular schwannomas consist completely or dominated from Antony
 areas where Verocay bodies my  not observed (Fig. 3). The most
ommon locations of cellular schwannomas are the paravertebral
reas in pelvis, retroperitonium and mediastinum [3,7,15]. The ﬂex-
form and melanotic schwannoma are other deﬁned histological
ypes. Tumor cells are widely and strongly stained with S-100, Leu-
 and Calretinin by immunohistochemical staining [3,8,15]. The
ytogenetic studies have showed that schwannomas have mono-
omy 22 or loss of material 22q [12,16]. In the present case, we
bserved wide areas of Antony A patterns which are rich from Vero-
ay bodies and poor areas of Antony B patterns containing smaller
umber of cells with lipoidization (Figs. 2 and 3). Additionally,
he tumor cells were stained with S-100 by immunohistochemi-
al staining (Fig. 5). The clinical signs and symptoms are related
ith the location and size of the tumor leading to motor or sensory
ysfunction depending on the tumor involvement of the nerves.
bdominal pain, nausea and vomiting, weight loss, melena, jaun-
ice, back and leg pain, may  be seen in intraabdominal localized
chwannomas [3,12,15]. In the series by Moriya et al. [3], abdom-
nal pain (57%) was the most observed symptom. Thirty percent
f the patients were asymptomatic. Weight loss (13%), back pain
6%), nausea and vomiting (4%), melena (4%) and jaundice (4%)
ere the other symptom and signs. The mean tumor diameter was
.2 ± 5.1 cm (range 1–20 cm). The present case was asymptomatic
ith a tumor size of 65 × 55 × 47 mm.  Diagnosis of asymptomatic
S patients is difﬁcult and CT is helpful to deliniate the anatomic
elationship between the tumor and surrounding tissues. Suzuki
t al. [9] demonstrated in CT images the cystic degenerative areas
nd reﬂection of Antoni B cystic components. Additionally, CT can
how degenerations depending on the tumor growth such as hem-
rrhage, cyst formation, necrosis and calciﬁcation. MRI  shows the
chwannomas as hypointense on T1-weighted images and hyper-Fig. 5. The S-100 positivity (H&E).
intense on T2-weighted images. But it can be confused easily with
other pancreatic tumors. Therefore, it should be considered in the
differential diagnosis [17]. EUS-FNA is valuable in diagnosing PS. In
cytological examination, schwannomas are characteristically com-
posed of spindle-shaped cells which formed vague cytoplasmic
boundaries and embedded a ﬁbrillar wavy nucleus and sometimes
has myxoid or collagen matrix. Antony A (adhesive clusters of
cells) and Antoni B (loose adherent or poorly cellular page) ﬁelds
is sometimes present. Immunohistochemical staining is a usually
required for accurate diagnosis [10,16]. S-100 protein positivity is
an important marker in the diagnosis of schwannoma. Li et al. [10]
used EUS-FNA and immunohistochemical staining together in the
diagnosis of PS. EUS-FNA is usually used in our clinic following mul-
tidetector triphasic contrast enhanced CT according to the clinical
situation. In the present case, EUS-FNA could not be done at that
time because of the breackdown of the endosonography device.
Enuclation is an effective treatment method because schwan-
nomas are usually encapsulated, slowly growing benign tumors
[3,18]. There is 10% documented recurrence in incomplete resec-
tions and continuous follow-up is recommended [19,20]. In
patients with PS, open (anterior, posterior or combined-methods)
or laparoscopic surgery can be used and the anterior approach
is generally suggested in retroperitoneal schwannoma. The arte-
rial or venous hemorrhages can be directly prevented with the
anterior approach. On the other hand, the posterior approach is fre-
quently used for intrasacral schwannomas [21]. Whipple procedure
or distal pancreatectomy can be performed in PS in which malig-
nant transformation could not be preoperatively ruled out. In the
series by Moriya et al. [3], 15 patients underwent pancreaticoduo-
denectomy (32%), 11 patients underwent distal pancreatectomy
(23%), 7 patients underwent enucleation (14%), and two patients
underwent resection (4%). The remaining patients were usually
unresectable or could not be operated [3,21]. Moriya et al. [3],
pointed out that malignant formation and cystic formation is
strongly associated with increase in tumor diameter. The high sus-
picion of malignancy in the present case with a past history of
malignant breast cancer was  the reason why we  choose Whipple
procedure in the management of this patient.
4. ConclusionPS is a rare tumor which should be taken into consider-
ation in the differential diagnosis of pancreatic cystic tumors.
Surgical resection is the treatment of choice and continuous follow-
up remains the standard of care in the management of PSs.
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